Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 3 | 2022 | 447 | 1.180 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 268 | 1.170 |
Why?
|
| Precision Medicine | 1 | 2023 | 28 | 0.760 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 196 | 0.680 |
Why?
|
| Health Expenditures | 2 | 2021 | 69 | 0.660 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 262 | 0.650 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 213 | 0.650 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2020 | 2 | 0.640 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 10 | 0.630 |
Why?
|
| Physicians | 1 | 2021 | 114 | 0.600 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 55 | 0.600 |
Why?
|
| Patient Discharge | 2 | 2017 | 152 | 0.530 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 18 | 0.510 |
Why?
|
| Humans | 16 | 2023 | 16832 | 0.470 |
Why?
|
| Appointments and Schedules | 2 | 2013 | 25 | 0.460 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2013 | 6 | 0.380 |
Why?
|
| Patient Admission | 1 | 2013 | 58 | 0.380 |
Why?
|
| Length of Stay | 4 | 2017 | 169 | 0.370 |
Why?
|
| Critical Care | 1 | 2013 | 62 | 0.370 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 374 | 0.360 |
Why?
|
| Pandemics | 2 | 2022 | 289 | 0.320 |
Why?
|
| Hospitals, Pediatric | 3 | 2013 | 73 | 0.250 |
Why?
|
| Prospective Studies | 2 | 2022 | 1186 | 0.240 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 1204 | 0.220 |
Why?
|
| Male | 3 | 2023 | 9556 | 0.210 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 1 | 0.200 |
Why?
|
| Cystitis, Interstitial | 1 | 2023 | 1 | 0.190 |
Why?
|
| Cost Sharing | 1 | 2023 | 28 | 0.190 |
Why?
|
| Child | 3 | 2022 | 2433 | 0.190 |
Why?
|
| Research Report | 1 | 2022 | 23 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 51 | 0.180 |
Why?
|
| Insurance Coverage | 1 | 2023 | 102 | 0.180 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2022 | 97 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 114 | 0.180 |
Why?
|
| Smoke | 1 | 2022 | 7 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2022 | 11 | 0.180 |
Why?
|
| Mentoring | 1 | 2022 | 29 | 0.170 |
Why?
|
| Cost of Illness | 1 | 2021 | 90 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 6 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 33 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 36 | 0.160 |
Why?
|
| Nephrologists | 1 | 2019 | 1 | 0.150 |
Why?
|
| Disease Management | 1 | 2020 | 106 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 130 | 0.150 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 322 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 51 | 0.150 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 63 | 0.150 |
Why?
|
| Aged | 4 | 2023 | 5901 | 0.140 |
Why?
|
| Incidence | 1 | 2022 | 1229 | 0.140 |
Why?
|
| Female | 3 | 2022 | 12193 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 5 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 8 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1098 | 0.130 |
Why?
|
| Risk Factors | 2 | 2022 | 3108 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2017 | 98 | 0.120 |
Why?
|
| Time Factors | 2 | 2017 | 989 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2017 | 305 | 0.120 |
Why?
|
| Young Adult | 1 | 2022 | 2456 | 0.120 |
Why?
|
| Adolescent | 1 | 2022 | 3464 | 0.110 |
Why?
|
| United States | 5 | 2023 | 3858 | 0.100 |
Why?
|
| Pennsylvania | 1 | 2013 | 23 | 0.100 |
Why?
|
| Hospital Bed Capacity | 1 | 2012 | 5 | 0.090 |
Why?
|
| Medicare | 2 | 2023 | 188 | 0.080 |
Why?
|
| Bed Occupancy | 1 | 2010 | 1 | 0.080 |
Why?
|
| Middle Aged | 1 | 2021 | 7515 | 0.070 |
Why?
|
| Adult | 1 | 2021 | 7255 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2013 | 2463 | 0.070 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 4 | 0.050 |
Why?
|
| Policy | 1 | 2023 | 19 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cystoscopy | 1 | 2023 | 4 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 9 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 40 | 0.050 |
Why?
|
| Parturition | 1 | 2022 | 7 | 0.040 |
Why?
|
| India | 1 | 2022 | 12 | 0.040 |
Why?
|
| Checklist | 1 | 2022 | 13 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2022 | 16 | 0.040 |
Why?
|
| Preferred Provider Organizations | 1 | 2019 | 1 | 0.040 |
Why?
|
| Vascular Access Devices | 1 | 2019 | 1 | 0.040 |
Why?
|
| Professional Practice | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 20 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 30 | 0.040 |
Why?
|
| Patients | 1 | 2019 | 29 | 0.040 |
Why?
|
| Self-Management | 1 | 2019 | 25 | 0.040 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 41 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 80 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 78 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 186 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2019 | 192 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 184 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1233 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 1555 | 0.030 |
Why?
|
| Crowding | 1 | 2012 | 2 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2012 | 11 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 56 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 84 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2012 | 292 | 0.020 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->